Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
05/2003
05/02/2003EP1304998A1 Enzyme composition for bleaching human keratinous fibres and bleaching method
05/02/2003EP1304921A2 Transgenic mice containing targeted gene disruptions
05/02/2003EP1304920A2 Transgenic mice containing targeted gene disruptions
05/02/2003EP1304916A1 Modification of plant resistance to diseases and/or pests
05/02/2003EP1304915A1 Modification of lignin biosynthesis
05/02/2003EP1151079A4 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use
05/02/2003EP0983366B1 Dna encoding an arthropod chitin synthase
05/02/2003EP0835316B1 PHENYLACETYL-CoA LIGASE FROM PENICILLIUM CHRYSOGENUM
05/02/2003EP0802983B1 Expression of urokinase plasminogen activator inhibitors
05/02/2003EP0730653B1 Arabinoxylan degrading enzymes
05/02/2003EP0728196B1 Mutants of a thermostable neutral protease from bacillus
05/02/2003EP0714435B1 Pro-urokinase mutants
05/02/2003EP0599971B1 Yeast promoter and use thereof
05/01/2003WO2003036264A2 Treating diseases mediated by metalloprotease-shed proteins
05/01/2003WO2003036255A2 Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property
05/01/2003WO2003035972A1 Oxidizing enzymes in the manufacture of paper materials
05/01/2003WO2003035891A2 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
05/01/2003WO2003035884A2 Transient immortalization
05/01/2003WO2003035879A2 Promoters to control cell differentiation
05/01/2003WO2003035878A2 Lipase variants
05/01/2003WO2003035877A1 PROCESSES FOR PRODUCING β-1,3-N-ACETYLGLUCOSAMINE TRANSFERASE AND N-ACETYLGLUCOSAMINE-CONTAINING COMPOSITE SACCHARIDE
05/01/2003WO2003035875A1 Method of elevating photosynthesis speed of plant by improving pyruvate phosphate dikinase
05/01/2003WO2003035871A1 Promoter dna
05/01/2003WO2003035862A2 Regulation of human arginase signature-containing protein
05/01/2003WO2003035861A2 Thrombin-cleavable chimeric proteins
05/01/2003WO2003035859A2 Regulation of human serine/threonine kinase
05/01/2003WO2003035858A2 Bacterial polypeptides involved in nucleic acid processing
05/01/2003WO2003035857A1 Regulation of human nad-dependent alpha-glycerol-3-phosphate dehydrogenase
05/01/2003WO2003035856A2 Protein with kinase activity
05/01/2003WO2003035844A2 Novel histone methyltransferase and methods of its use
05/01/2003WO2003035840A2 69583 and 85924, novel human protein kinase family members and uses therefor
05/01/2003WO2003035828A2 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli
05/01/2003WO2003035827A2 Plasticized hydrophilic glasses for improved stabilization of biological agents
05/01/2003WO2003035826A2 Genetic screening methods
05/01/2003WO2003035693A2 Crystals of cytochrome p450 2c9, structures thereof and their use
05/01/2003WO2003035681A2 Mycobacterial genes down-regulated during latency
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003035673A1 Supercritical fluids processing: preparation of protein microparticles and their stabilisation
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035097A1 A method for identification and development of therapeutic agents
05/01/2003WO2003035060A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
05/01/2003WO2003035012A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2003034813A2 Synthetic herbicide resistance gene
05/01/2003WO2003034812A2 Aromatic methyltransferases and uses thereof
05/01/2003WO2003000875A3 Vitamin b6-phosphate phosphatase
05/01/2003WO2002100199A3 Modifying nicotine and nitrosamine levels in tobacco
05/01/2003WO2002095127A3 Use of lipolytic enzymes for stickies control
05/01/2003WO2002092798A3 Regulation of human phosphatidic acid phosphatase type 2c-like protein
05/01/2003WO2002092741A3 0etergent compositions comprising bacillus subtilis pectate lyases
05/01/2003WO2002064761A3 Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein
05/01/2003WO2002061068A3 Oxidase free of catalase side activities
05/01/2003WO2002060939A8 Method for increasing the sulphur-compound content in plants
05/01/2003WO2002057471A3 Maize chloroplast aldolase promoter compositions and methods for use thereof
05/01/2003WO2002057433A3 Homeodomain-interacting protein kinases and the use of the same for influencing cell division and cell proliferation
05/01/2003WO2002055679A3 Thermostable lipolytic enzyme variant
05/01/2003WO2002053750A3 Inactivation of the polyphosphate kinase gene for microbial overproduction of antibiotics or enzymes
05/01/2003WO2002046433A3 Tnf-inducible promotors and methods for using them
05/01/2003WO2002044392A3 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants
05/01/2003WO2002040544A9 Mutant human factor ix with an increased resistance to inhibition by heparin
05/01/2003WO2002036783A3 Regulation of human histone deacetylase
05/01/2003WO2002026956A9 Calcium free subtilisin mutants
05/01/2003WO2002012466A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
05/01/2003US20030084487 Methods for transforming coffee plants to suppress expression of coffee fruit-expressed ACC synthase and/or coffee fruit-expressed ACC oxidase necessary for ethylene biosynthesis and ripening of coffee fruit
05/01/2003US20030084485 Comprising overexpressing a molybdenum cofactor sulfurase in the plant; improving drought resistance, freeze resistance, salt tolerance of plants
05/01/2003US20030084480 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acid levels
05/01/2003US20030084479 Nucleic acid encoding a homogentisate phytyltransferase and a sequence encoding a plastid transit peptide, functionally linked to regulatory signals which ensure transcription and translation in prokaryotic or eukaryotic organisms
05/01/2003US20030084478 Plants having enhanced gall resistance and methods and ocmpositions for producing same
05/01/2003US20030084476 DNA polymerase eta ( Poleta) cDNA and uses thereof
05/01/2003US20030084473 Non-transgenic herbicide resistant plants
05/01/2003US20030084472 Useful for genetic manipulation of plant characteristics, identification, isolation and introduction of genes useful for altering seed oil content, seed size, flowering and/or generation time, or vegetative growth of commercial crops
05/01/2003US20030084464 Methods of detecting genetic alterations associated with abdominal wall defects; gastroschisis
05/01/2003US20030083485 Nucleotide sequences coding polypeptide for use the treament of cardiovascular disorders
05/01/2003US20030083480 Novel glyphosate N-acetyl transferase (GAT) genes
05/01/2003US20030083479 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083467 Fusion proteins for use in the treatment of tumors and nervous sytem disorders
05/01/2003US20030083462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083304 CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment
05/01/2003US20030083282 Antisense modulation of stearoyl-CoA desaturase expression
05/01/2003US20030083277 Use of insulin degrading enzyme (IDE) for the treatment of alzheimer's disease in patients
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083248 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083234 Anti-angiogenesis methods, compositions and uses therefor
05/01/2003US20030082799 Low-temperature inducible expression vector
05/01/2003US20030082793 Method for preparation of physiologically active water-base extract and method for potentiating the activity thereof
05/01/2003US20030082787 Plant histidine biosynthetic enzymes
05/01/2003US20030082786 PEG-modified uricase
05/01/2003US20030082785 24554, a human ubiquitin carboxyl-terminal hydrolase family member and uses therefor
05/01/2003US20030082783 Nucleotide sequences coding polypeptide for use in the treatment and prevention of infections and tumors
05/01/2003US20030082782 Proteolytic enzymes; m edical diagnosis; drug screening; treatment of juvenile amyotrophic lateral sclerosis
05/01/2003US20030082780 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases
05/01/2003US20030082779 BGL3 beta-glucosidase and nucleic acids encoding the same
05/01/2003US20030082777 Polyhydroxyalkanoate synthase and gene encoding the same enzyme
05/01/2003US20030082776 Nucleotide sequences coding enzymatic polypeptide for use in therapeutic drug design
05/01/2003US20030082775 Carbamoyl-phosphate synthetase gene of coryneform bacteria and method for producing L-arginine
05/01/2003US20030082774 Nucleotide sequences coding enzymatic polypeptide for use in the generation of arginine
05/01/2003US20030082773 Crystal of pantothenate synthetase for use in drug design
05/01/2003US20030082772 Amine oxidase for use in the treatment of nervous system disorders
05/01/2003US20030082771 Nucleic acids encoding human adamalysin SVPH1-8
1 ... 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 ... 1416